Lantern Pharma Inc (LTRN)
6.13
-0.01
(-0.16%)
USD |
NASDAQ |
May 17, 16:00
6.00
-0.13
(-2.12%)
After-Hours: 20:00
Lantern Pharma Shareholders Equity (Quarterly): 35.77M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 35.77M |
December 31, 2023 | 40.91M |
September 30, 2023 | 45.41M |
June 30, 2023 | 48.26M |
March 31, 2023 | 52.58M |
December 31, 2022 | 56.04M |
September 30, 2022 | 59.03M |
June 30, 2022 | 61.08M |
March 31, 2022 | 65.32M |
Date | Value |
---|---|
December 31, 2021 | 71.57M |
September 30, 2021 | 75.73M |
June 30, 2021 | 79.61M |
March 31, 2021 | 81.73M |
December 31, 2020 | 19.70M |
September 30, 2020 | 21.57M |
June 30, 2020 | 23.23M |
March 31, 2020 | 0.5365M |
December 31, 2019 | 0.9433M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.5365M
Minimum
Mar 2020
81.73M
Maximum
Mar 2021
46.61M
Average
50.42M
Median
Shareholders Equity (Quarterly) Benchmarks
Eyenovia Inc | 1.818M |
Cassava Sciences Inc | 78.60M |
Alpine Immune Sciences Inc | 332.70M |
Clearside Biomedical Inc | -21.81M |
Poseida Therapeutics Inc | 84.59M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 39.73M |
Total Liabilities (Quarterly) | 3.969M |